News

Meet the ResearchDx team at the Association for Molecular Pathology (AMP) 2026 Annual Meeting & Expo in Seattle, Washington, November 10–14. Visit

ResearchDx and Proteomics International are pleased to announce the American Medical Association has approved a new dedicated CPT® Proprietary Laboratory Analyses (PLA)

ResearchDx and Targeted Genomics are thrilled to announce that the GlutenID Celiac Genetic Health Risk Test has received FDA 510(k) clearance (K241456)

Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ), and ResearchDx DBA PacificDx proudly announce ProMarkerD, the groundbreaking predictive test for diabetic kidney

The 2025 ASCO (American Society of Clinical Oncology) Annual Meeting is the largest global oncology conference, taking place in Chicago, IL, from

FibroSIGHT™ is Here: A New Standard in Clinical Care of MASH Patients. FibroSIGHT enables sensitive detection and visualization of MASH liver fibrosis,

Prostatype Genomics receives CAP laboratory accreditation, achieves another milestone towards entering the US market for their groundbreaking Prostatype Gene Test Read Prostatype

Heranova announces succesful CLIA certification and Early access launch of their groundbreaking HerResolve™, a Potential First FDA-Cleared, Non-Invasive Endometriosis Test Read Heranova’s

Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection Read Vesica Health’s announcement @Vesicahealth